Chugai Selected as “KENKO Investment for Health” for the Second Consecutive Year

TOKYO, March 10, 2025 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that it has been selected as a “2025 KENKO Investment for Health” by the Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange (TSE) as an exceptional TSE-listed enterprises engaging in KENKO Investment for Health. The selection as a “KENKO Investment for Health” marks the second consecutive year following last year. The company has also been certified as the top 500 enterprise (White 500) in the “2025 Outstanding Organization of KENKO Investment for Health (Large Enterprise Category)” for five consecutive years since 2021.

The KENKO Investment for Health has been jointly selected by METI and TSE to promote the health management initiatives of listed enterprises by selecting listed enterprises that consider the employees’ health management from the perspective of management and engage in a strategic manner, and introducing the enterprises to investors who emphasize the improvement of corporate value from the long-term point of view. Specifically, the selection was made on the basis of one enterprise per industry from listed enterprises within the top 500 applicants to the Outstanding Organizations of KENKO Investment for Health (large enterprise category).

“Recognizing that ‘human resources’ are the key to realizing advanced and sustainable patient-centric healthcare, we are promoting work satisfaction reforms to ensure that each employee can work proactively and autonomously, finding fulfillment and purpose in their work, and thriving both mentally and physically. We have identified ‘Employee well-being’ as one of our material issues, recognizing that employee health is the foundation of all our business activities. We continuously implement systems and initiatives that promote health and well-being. I’m pleased that these efforts have led to our selection for the second consecutive year,” said Mr. Yoshiyuki Yano, Chugai’s Executive Vice President, Supervisory responsibility for Human Resource Management and ESG.

Based on its basic philosophy that human resources are an invaluable asset that creates corporate growth and development, Chugai will continue developing a work environment and organizational culture that enables all employees to participate actively.

[Reference]

Health and Productivity Management:
https://www.chugai-pharm.co.jp/english/sustainability/healthmanagement/index.html

External Evaluations:
https://www.chugai-pharm.co.jp/english/sustainability/evaluation/index.html